返回
F
Fabio Puglisi
centro di riferimento oncologico aviano
59H指数
762论文数
1.6W被引数
收录论文 318
发表时间
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease曲妥珠单抗德鲁替康在激素受体阳性、HER2低/超低表达转移性乳腺癌(DESTINY-Breast06):基于先前一线内分泌联合CDK4/6抑制剂治疗至进展时间和基线疾病负担的疗效分析
Annals of Oncology
IF65.4

